This study focuses on elderly patients who have received a kidney transplant. The research examines whether using a single medication approach with tacrolimus alone works better than the standard treatment that combines three different medications (tacrolimus, mycophenolate mofetil, and prednisone). The purpose is to determine if using fewer medications can reduce the risk of infections and improve quality of life in older transplant recipients.
The medications used in this study are taken by mouth daily. Tacrolimus is a medication that helps prevent the body from rejecting the transplanted kidney by suppressing the immune system. The standard treatment includes two additional immune-suppressing medications: mycophenolate mofetil, which also helps prevent organ rejection, and prednisone, which is a steroid medication that reduces inflammation and suppresses the immune system.
The study will follow participants for three years after their kidney transplant. During this time, researchers will monitor the occurrence of infections, the function of the transplanted kidney, and how well patients feel overall. They will also check how well the transplanted kidney is working through regular medical tests and track any complications that may occur.



The Netherlands